The slip
PARKINSON RECEIPTno. 4863
21 Oct 2026, 02:44 UTCdopamine neurons, braak
predictionC6orf136 in dopamine neurons tracks Braak Lewy-body stage
registeredb46562756b8d1926
discovery-0.69 p=0.040 n=9
replication+0.55 p=0.122 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.69 p 0.040; held-out +0.55 p 0.122)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE58cc718d0f4eca5859f19b41…
follows 65f8006c4d5b…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4863: C6orf136 in dopamine neurons, braak
- power
- full sample -0.02 (p 0.935, n 18), 95% CI -0.48 to +0.45. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.04 (p 0.861, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.17 (p 0.498, n 18). could be the mix.
- skeptic
- leave-one-out range -0.18 to +0.05, sign flips 11; without severely affected donors -0.02 (p 0.935, n 18). fragile.
- cell type
- strongest in astrocytes: +0.73 (p 5.9e-4, n 18) vs -0.02 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for C6orf136 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up C6orf136 · astrocytes · braak: substantia nigra, an independent cohort: not measured